Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma

MSKCC, New York

Northwell Health, Lake Success

Roswell Park Cancer Institute, Buffalo

UPMC, Pittsburgh

Thomas Jefferson University, Philadelphia

Johns Hopkins, Baltimore

Duke University, Durham

Northside Hospital, Sandy Springs

Mayo Clinic Jacksonville, Jacksonville

Moffitt Cancer Center, Tampa

Vanderbilt University, Nashville

Ohio State University, Columbus

Cleveland Clinic, Cleveland

University of Iowa, Iowa City

Medical College of Wisconsin, Milwaukee

Mayo Clinic Rochester, Rochester

Washington University St. Louis, St Louis

MD Anderson, Houston

University of Colorado Denver, Aurora

University of Utah, Huntsman Cancer Institute, Salt Lake City

University of Arizona Cancer Center, Tucson

Sarcoma Oncology Center, Santa Monica

Stanford University, Palo Alto

University of Washinton, Seattle

Massachusetts General Hospital, Boston

Dana Farber Cancer Institute, Boston

Medical University,Vienna, Vienna

Institut Bergonié, Bordeaux

Centre Oscar Lambret, Lille

Centre Léon Bérard, Lyon

Institut Gustave Roussy, Villejuif

Helios Klinikum, Bad Saarow

Mannheim University Medical Center, Mannheim

Klinikum derUniversitat Munchen, Munich

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Memorial Cancer Center and Institute of Oncology, Warsaw

Institut Català d'Oncologia (ICO), Barcelona

12 de Octubre University Hospital, Madrid

Royal Marsden NHS, Chelsea